Conference abstractPublished 27 Nov 2017
Fuzi combined with radiotherapy confers significant antitumor effect via decreasing the proportion of regulatory T (Treg) cells
Jinshan Hospital-Fudan University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fuzi, a traditional Chinese medicine is widely used as an antitumor agent in China. However, its mechanism of antitumor is not clear by now. In the present study, the antitumor effect and mechanism of Fuzi combined with radiotherapy were examined in vivo on Lewis lung carcinoma in mice. Through the treatment of Fuzi combined with radiotherapy, we examined whether Fuzi has the effect of radiosensitization on Lewis lung cancer cells. We found that treatment of Fuzi combined with radiotherapy significantly inhibited the growth of Lewis lung cancer, which can prolong the survival time of mice. Furthermore, the efficacy of Fuzi in decreasing the proportion of the irradiation-induced Treg cells were regulated by some cytokines, such as interleukin (IL)-10 and transforming growth factor (TGF)-Ã?². We also found that the antitumor mechanism probably depended on the decrease of the expression level of irradiation-induced programmed death ligand-1 (PD-L1) in local tumor cells. These data suggested that Fuzi can be used as an immunomodulatory drug in preventing irradiation-induced immunity disorder.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Tiankui Qiao”
- BylineArticles whose byline prints “Qi Zhang”
